ArticleNature communications2026
Nek1 defines a branch of centriolar microtubule length control parallel to CP110-Cep97.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Centrioles maintain a characteristic length throughout the cell cycle, which is essential for the accurate functioning of centrosomes and ciliogenesis. The CP110-Cep97 complex acts as a cap on the distal end of the centriole, restricting microtubule extension. However, whether CP110-Cep97 alone or in conjunction with additional players regulates this process remains unclear. In this study, we identify the kinase Nek1 (NIMA-related kinase 1) as a key factor that works with the CP110-Cep97 complex to control centriole length. Nek1 localizes alongside CP110 and Cep97 at the distal end of the centriole and interacts with Cep97 and Cep78. Loss of Nek1 induces pronounced centriolar microtubule hyperelongation without displacement of the CP110-Cep97 complex, indicating that Nek1 restricts centriole extension through a distinct mechanism. Co-depletion of Nek1 and CP110, but not Cep78, further enhances the hyperelongation phenotype, demonstrating that Nek1 and CP110 pathways act in parallel to maintain centriole length in cycling cells. Notably, Nek1 is removed from the basal body during ciliogenesis in a Cep78-dependent manner, thereby linking Cep78 to the spatial regulation of Nek1 activity. Together, these findings establish Nek1 as an important safeguard that works with the CP110-Cep97 complex to ensure the structural integrity of centrioles.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.